The immune system must recognize self antigens to prevent attacks on healthy cells and tissues. To control antigen recognition, immune checkpoint proteins inactivate or activate immune cells in response to self or foreign antigens, respectively. Cancer cells take advantage of these checkpoints to evade immune cells and escape destruction; however, scientists have developed immune checkpoint inhibitor drugs to thwart this sneaky maneuver and help immune cells effectively recognize and destroy cancer cells.
Download this explainer from Drug Discovery News to learn how immune checkpoint inhibitor drugs work and explore their effect on tumor cells and healthy tissue.
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2025 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy